News & Updates
Filter by Specialty:
Letrozole-abemaciclib plus metformin shows promise in endometrial cancer treatment
Adding metformin to letrozole and abemaciclib does not cause serious safety concerns and may even encourage favourable responses among patients with oestrogen receptor (ER)-positive recurrent endometrial cancer (EC), according to a phase II study presented at SGO 2025.
Letrozole-abemaciclib plus metformin shows promise in endometrial cancer treatment
05 May 2025
Metformin shows knee OA pain-relieving potential
Metformin, a common medication for diabetes, appears to produce a moderate reduction in knee pain and stiffness for overweight or obese individuals with symptomatic knee osteoarthritis (OA), as shown in the results of a randomized clinical trial.
Metformin shows knee OA pain-relieving potential
03 May 2025
LHRH analogues vs tE2 patches: Which work best for prostate cancer?
The use of transdermal oestradiol (tE2) or oestrogen patches helps suppress testosterone and prostate-specific antigen (PSA) in men with locally advanced prostate cancer, with similar efficacy to that of luteinizing hormone-releasing hormone (LHRH) analogues, reports a study presented at EAU 2025.
